Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
26,725,442
-
Shares change
-
+5,379,294
-
Total reported value, excl. options
-
$558,325,760
-
Value change
-
+$113,660,788
-
Number of buys
-
40
-
Number of sells
-
-11
-
Price
-
$20.89
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q1 2021
62 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q1 2021.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,725,442 shares
of 75,893,250 outstanding shares and own 35.2% of the company stock.
Largest 10 shareholders include BVF INC/IL (7,285,071 shares), FEDERATED HERMES, INC. (3,084,257 shares), BAKER BROS. ADVISORS LP (2,037,469 shares), BOXER CAPITAL, LLC (1,900,000 shares), WELLINGTON MANAGEMENT GROUP LLP (1,825,903 shares), Medicxi Ventures Management (Jersey) Ltd (1,600,000 shares), Sofinnova Investments, Inc. (1,311,039 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1,113,706 shares), MPM Oncology Impact Management LP (700,879 shares), and Avoro Capital Advisors LLC (665,000 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.